Home » Topics » BioWorld Science

BioWorld Science
RSS

CTA approved in Vietnam for phase I/II/III study of SARS-CoV-2 vaccine ARCT-154

Aug. 3, 2021

Phase I data with ANG-3070 pave way for phase II study in primary proteinuric kidney diseases

Aug. 3, 2021

Phase I trial evaluates iPSC-derived CAR T-cell therapy FT-819 for CD19+ malignancies

Aug. 3, 2021

ST-067 enters first-in-human study in relapsed or refractory solid tumors

Aug. 3, 2021

Intranasal vaccination with ChAdOx1 nCoV-19 reduces viral shedding in preclinical models

Aug. 3, 2021

Abcentra studies orticumab in subjects with psoriasis and cardiometabolic risk factors

Aug. 3, 2021

Collagenase clostridium histolyticum improves foot function in plantar fibromatosis study

Aug. 3, 2021

China's NMPA approves INDs for IASO's CD19/CD22 CAR-T therapy

Aug. 3, 2021

Gem gene sparkles as ischemic stroke drug discovery target

Aug. 3, 2021

Phase II data show safety and efficacy of OCS-02 in dry eye disease

Aug. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...